Sean Freeman - NuVasive Sr Devel

NUVADelisted Stock  USD 42.35  0.85  1.97%   

Insider

Sean Freeman is Sr Devel of NuVasive
Phone858 909 1800
Webhttps://www.nuvasive.com

NuVasive Management Efficiency

The company has return on total asset (ROA) of 0.0242 % which means that it generated a profit of $0.0242 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0331 %, meaning that it created $0.0331 on every $100 dollars invested by stockholders. NuVasive's management efficiency ratios could be used to measure how well NuVasive manages its routine affairs as well as how well it operates its assets and liabilities.
NuVasive currently holds 1.01 B in liabilities with Debt to Equity (D/E) ratio of 1.22, which is about average as compared to similar companies. NuVasive has a current ratio of 1.15, suggesting that it may not be capable to disburse its financial obligations when due. Note, when we think about NuVasive's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Mory GharibGlaukos Corp
N/A
Michael HutchinsonLivaNova PLC
54
S MansbachAvanos Medical
N/A
Lee RosenthalParagon 28
N/A
McAlister MarshallInteger Holdings Corp
51
David HaffnerGlaukos Corp
N/A
Karen PrangeNevro Corp
56
Michelle ScharfenbergAvanos Medical
N/A
Mojirade JamesAvanos Medical
58
Kerr HolbrookAvanos Medical
58
Diane BiagiantiGlaukos Corp
64
David CrawfordAvanos Medical
N/A
Denice TorresGlaukos Corp
60
Steve DeitschParagon 28
N/A
Diana SchererGlaukos Corp
N/A
Richard CarterNevro Corp
53
Erik MickelsonParagon 28
42
Urban FaehBruker
N/A
L KatzGlaukos Corp
N/A
Brendan ShookParagon 28
N/A
Joseph PowersSi Bone
64
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. Nuvasive operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2900 people. NuVasive (NUVA) is traded on NASDAQ Exchange in USA and employs 3,000 people.

Management Performance

NuVasive Leadership Team

Elected by the shareholders, the NuVasive's board of directors comprises two types of representatives: NuVasive inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NuVasive. The board's role is to monitor NuVasive's management team and ensure that shareholders' interests are well served. NuVasive's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NuVasive's outside directors are responsible for providing unbiased perspectives on the board's policies.
Juliet Cunningham, VP Relations
Sean Freeman, Sr Devel
Michael Farrington, VP Culture
Nathaniel Esq, Gen VP
Dale Wolf, VP Operations
Ryan Donahoe, VP Officer
Matthew Harbaugh, Ex CFO
Johnson Lai, Chief Officer
Marc Rosenbaum, Co VP
Christopher Barry, CEO, Director

NuVasive Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NuVasive a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Consideration for investing in NuVasive Stock

If you are still planning to invest in NuVasive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NuVasive's history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins